NCT01169844View on ClinicalTrials.gov

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Psoriatic Arthritis
Interventions
BIOLOGICAL

AIN457A

OTHER

Other

Trial Locations (6)

1100

Novartis Investigative Site, Amsterdam

6231

Novartis Investigative Site, Meerssen

22415

Novartis Investigative Site, Hamburg

G12 8TA

Novartis Investigative Site, Glasgow

LS7 4SA

Novartis Investigative Site, Leeds

NE2 4HH

Novartis Investigative Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY